If you don't know how the subgroup was clinically defined, then how can you have any idea as to whether or not the results with advexin in this subpopulation are better or worse than the current standard of care?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.